Related Experiment Video
Updated: Jul 17, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding
Can Kocabas1, Nora Katsenelson, Sunita Kanswal
1Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research, U. S. Food and Drug Administration, 1410 Rockville Pike (HFM-428), Rockville, MD 20852-1448, USA.
Abstract:
Encapsulated Neisseria meningitidis can invade mucosal barriers and cause systemic diseases. Activation of the innate immune system by conserved meningococcal molecules such as lipooligosaccharides (LOS) is essential for the generation of an effective host immune response. Here we show that the type C capsular polysaccharide of N. meningitidis (MCPS) inhibited LOS-induced interleukin-6 and TNF-alpha secretion from monocytes, and blocked the maturation of dendritic cells induced by LOS, while the capsular polysaccharide from group B streptococcus type III and t(4-hydroxy-3-nitrophenyl) acetyl (NP)-Ficoll had no such effect. MCPS also inhibited the LOS-induced NF-kappaB activation and phosphorylation of signalling molecules such as ERK1/2, p38 and Jun N-terminal kinase. In a direct binding assay, MCPS manifested a concentration-dependent binding to recombinant lipoprotein binding protein and CD14, the two members of the LOS receptor complex. In addition, the binding of LOS to CD14 and lipopolysaccharide binding protein was inhibited by MCPS. We established that MCPS binding to CD14 is responsible for the inhibition of LOS-mediated cell activation because MCPS inhibition of LOS was reversed when access amounts of CD14 were added to culture media of HEK293 cells expressing TLR4 and MD-2, and the magnitude of recovery in LOS stimulation correlated with the increase in CD14 concentration. These results suggest a new virulence property of meningococcal capsular polysaccharides.
Insights
The meningococcal type C capsular polysaccharide (MCPS) blocks immune responses to bacterial lipooligosaccharides (LOS). MCPS inhibits LOS-induced inflammation and immune cell maturation by binding to LOS receptors.
Area of Science:
- Immunology
- Microbiology
- Molecular Biology
Background:
- Neisseria meningitidis causes systemic diseases by invading mucosal barriers.
- Activation of the innate immune system by lipooligosaccharides (LOS) is crucial for host defense.
- Conserved meningococcal molecules are key targets for immune activation.
Purpose of the Study:
- To investigate the role of meningococcal type C capsular polysaccharide (MCPS) in modulating host immune responses to LOS.
- To determine the mechanism by which MCPS affects LOS-mediated immune cell activation.
- To identify potential new virulence properties of meningococcal capsular polysaccharides.
Main Methods:
- Monocyte and dendritic cell cultures stimulated with LOS.
- Measurement of cytokine secretion (IL-6, TNF-alpha) and immune cell maturation markers.
- Analysis of NF-kappaB activation and MAPK signaling pathways (ERK1/2, p38, JNK).
- Direct binding assays of MCPS to LOS receptor components (LBP, CD14).
- Functional assays using HEK293 cells expressing TLR4/MD-2 to assess MCPS inhibition of LOS signaling.
Main Results:
- MCPS significantly inhibited LOS-induced IL-6 and TNF-alpha secretion from monocytes.
- MCPS blocked LOS-induced maturation of dendritic cells.
- MCPS suppressed LOS-induced NF-kappaB activation and MAPK signaling.
- MCPS directly bound to LBP and CD14, inhibiting LOS binding to these receptors.
- MCPS inhibition of LOS-mediated activation was dependent on CD14 availability.
Conclusions:
- Meningococcal type C capsular polysaccharide (MCPS) possesses a novel virulence property by inhibiting innate immune responses to LOS.
- MCPS interferes with the LOS-CD14-TLR4/MD-2 pathway, dampening inflammation and immune cell activation.
- These findings reveal a mechanism by which Neisseria meningitidis may evade host immunity.
More Related Videos
Related Concept Videos
Formation of Lipopolysaccharides
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Cryptococcal Meningitis
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors Of Virion Release

